Business
Joint Broker Appointment
Joint Broker Appointment.
About this update from Fenikso Ltd
[{"type":"text","content":"\n \n \n \n RNS Number : 4614L\n Lekoil Limited\n 13 January 2021\n \n \n \n \n 13\n January 2021\n \n \n \n \n \n Lekoil Limited\n \n \n (\"LEKOIL\" or the \"Company\")\n \n \n \n \n \n Joint Broker Appointment\n \n \n LEKOIL (AIM: LEK), the oil and gas exploration and production company with a focus on Nigeria and West Africa, is pleased to announce that it has appointed Tennyson Securities to act as the Company's Joint Broker alongside SP Angel Corporate Finance LLP with immediate effect. Tennyson Securities is the new home of the Primary Team that has recently left Mirabaud Securities Limited, providing continuity of the Company's broking relationships.\n \n \n \n \nThe information contained within this announcement is deemed by the Company to constitute inside information stipulated under the Market Abuse Regulation (EU) No. 596/2014. Upon the publication of this announcement via the Regulatory Information Service, this inside information is now considered to be in the public domain.\n \n \n \n \n \n For further information, please visit \n \n \n www.lekoil.com\n \n \n or contact:\n \n \n \n \n \n LEKOIL Limited\n \n \n Hamilton Esi, Corporate Communications\n \n \n Ore Bajomo, Investor Relations\n \n \n \n \n +44 20 7457 2020\n \n \n \n \n \n \n SP Angel Corporate Finance LLP (Nominated Adviser and Joint Broker)\n \n \n John Mackay / Jeff Keating / Stuart Gledhill / Richard Hail\n \n \n \n \n \n \n \n +44 20 3470 0470\n \n \n \n \n \n \n Tennyson Securities (Joint Broker)\n \n \n Peter Krens / Edward Haig-Thomas\n \n \n \n \n +44 20 7186 9030\n \n \n \n \n \n \n Instinctif (Financial PR)\n \n \n Mark Garraway / Galyna Kulachek / Sarah Hourahane\n \n \n \n \n +44 20 7457 2020\n \n \n [email protected]\n \n \n \n \n \n \n \n \n \n This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an ano...